We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.
- Authors
Lessa, Fernanda C; Mu, Yi; Ray, Susan M; Dumyati, Ghinwa; Bulens, Sandra; Gorwitz, Rachel J; Fosheim, Gregory; DeVries, Aaron S; Schaffner, William; Nadle, Joelle; Gershman, Kenneth; Fridkin, Scott K; Active Bacterial Core surveillance (ABCs); MRSA Investigators of the Emerging Infections Program
- Abstract
The USA300 methicillin-resistant Staphylococcus aureus (MRSA) strain, which initially emerged as a cause of community-associated infections, has recently become an important pathogen in healthcare-associated infections (HAIs). However, its impact on patient outcomes has not been well studied. We evaluated patients with invasive MRSA infections to assess differences in outcomes between infections caused by USA100 and those caused by USA300.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Vol 55, Issue 2, p232
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1093/cid/cis408